Cargando…
Quantifying infection risks in incompatible living donor kidney transplant recipients
Desensitization has enabled incompatible living donor kidney transplantation (ILDKT) across HLA/ABO barriers, but added immunomodulation might put patients at increased risk of infections. We studied 475 recipients from our center from 2010 to 2015, categorized by desensitization intensity: none/com...
Autores principales: | Avery, Robin K., Motter, Jennifer D., Jackson, Kyle R., Montgomery, Robert A., Massie, Allan B., Kraus, Edward S., Marr, Kieren A., Lonze, Bonnie E., Alachkar, Nada, Holechek, Mary J., Ostrander, Darin, Desai, Niraj, Waldram, Madeleine M., Shoham, Shmuel, Steinke, Seema Mehta, Subramanian, Aruna, Hiller, Janet M., Langlee, Julie, Young, Sheila, Segev, Dorry L., Garonzik Wang, Jacqueline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972996/ https://www.ncbi.nlm.nih.gov/pubmed/32949093 http://dx.doi.org/10.1111/ajt.16316 |
Ejemplares similares
-
Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023) -
Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort
por: Avery, Robin K., et al.
Publicado: (2021) -
Coronavirus Disease 2019–Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics
por: Permpalung, Nitipong, et al.
Publicado: (2023) -
Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
por: Nguyen, Michelle C., et al.
Publicado: (2021) -
Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics
por: Sait, Afrah S., et al.
Publicado: (2021)